Joshua M. Eizen - Oct 14, 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Chief Legal Officer
Signature
/s/ Lucy Day, Attorney-in-Fact for Joshua M. Eizen
Stock symbol
ANTX
Transactions as of
Oct 14, 2022
Transactions value $
$0
Form type
4
Date filed
10/28/2022, 06:03 PM
Previous filing
Oct 5, 2022
Next filing
Feb 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANTX Stock Option (right to buy) Award $0 +92K $0.00 92K Oct 14, 2022 Common Stock 92K $17.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as follows: 25% of the shares shall vest on the anniversary of September 29, 2022, and the remainder of the shares shall vest ratably monthly over the subsequent 36 months.